VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 132 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $432 | -94.0% | 100 | -90.9% | 0.00% | – |
Q2 2023 | $7,249 | -2.9% | 1,100 | 0.0% | 0.00% | – |
Q1 2023 | $7,469 | -8.1% | 1,100 | 0.0% | 0.00% | – |
Q4 2022 | $8,129 | -18.7% | 1,100 | 0.0% | 0.00% | – |
Q3 2022 | $10,000 | -9.1% | 1,100 | 0.0% | 0.00% | – |
Q2 2022 | $11,000 | +1000.0% | 1,100 | +1000.0% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | -50.0% | 100 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | +100.0% | 100 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | – | 100 | 0.0% | 0.00% | – |
Q3 2020 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | -100.0% | 100 | -100.0% | 0.00% | -100.0% |
Q1 2019 | $6,981,000 | -71.6% | 379,404 | -59.6% | 0.04% | -73.9% |
Q4 2018 | $24,545,000 | +29.6% | 939,374 | +13.8% | 0.15% | +51.5% |
Q3 2018 | $18,942,000 | +3.9% | 825,375 | -13.7% | 0.10% | -3.8% |
Q2 2018 | $18,228,000 | +607500.0% | 956,866 | +478333.0% | 0.10% | – |
Q1 2018 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q4 2017 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q3 2017 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q2 2017 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | – |
Q4 2016 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q3 2016 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | – |
Q2 2016 | $2,000 | +100.0% | 200 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q4 2015 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | – |
Q3 2015 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q2 2015 | $2,000 | +100.0% | 200 | 0.0% | 0.00% | – |
Q1 2015 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | – |
Q4 2014 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q3 2014 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | – |
Q2 2014 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q1 2014 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | – |
Q4 2013 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q3 2013 | $2,000 | +100.0% | 200 | 0.0% | 0.00% | – |
Q2 2013 | $1,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |